SARS CoV 2 News and Research

RSS

How effective have COVID-19 control measures been in the UK?

Researchers in the UK and Australia have shown that epidemiologic models accounting for people’s behavior outside of measures introduced to control the coronavirus disease-19 (COVID-19) pandemic improve estimates of how effective such interventions have been.

21 Dec 2020

COVID-19 spread in cities driven by socioeconomically weaker groups, study finds

Researchers in Sweden have conducted a study showing that the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within cities is driven by socioeconomically weaker and high-mobility groups. They used Basel, Switzerland as their case study.

21 Dec 2020

SARS-CoV-2 spike protein remains remarkably conserved among 37 variants from Hong Kong

As the coronavirus disease 2019 (COVID-19) pandemic continues to intensify in many parts of the world, vaccine development is proceeding apace.

21 Dec 2020

SARS-CoV-2 RNA in serum associated with poor prognosis and high mortality

A new preprint indicates the direct correlation between the presence of detectable viral RNA loads in serum, and clinical severity and death.

21 Dec 2020

Cross-reactive coronavirus antibodies shape COVID-19 convalescent plasma functionality

The onset of the current COVID-19 pandemic revealed the seventh known pathogenic human coronavirus, SARS-CoV-2.

21 Dec 2020

South Korean city shows SARS-CoV-2 clade shift from V to GH over time

A new paper from South Korea describes the evolving SARS-CoV-2 genome in a single city, that of Gwangju, in the southwestern region of this country.

21 Dec 2020

Detecting SARS-CoV-2 sequences in blood monocytes

A meeting with doctors from Wuhan presented a compelling observation to Professor Laura Manuelidis, MD, from the Yale Medical School early in 2020.

21 Dec 2020

FDA issues first emergency use authorization for second COVID-19 vaccine

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

21 Dec 2020

Study: COVID-19 pandemic may have contributed to avoidable heart-related deaths in England

Lower rates of hospital attendance for urgent heart problems during the initial phase of the COVID-19 pandemic may have contributed to avoidable deaths in England, finds a new study led by UCL researchers.

20 Dec 2020

Zika infection affects fetal retinal development during pregnancy but not after birth

While the SARS-CoV-2 virus has dominated the news this past year, researchers continue to study the health effects of the Zika virus, which has been reported in 86 countries globally.

18 Dec 2020

AOAC INTERNATIONAL issues Certificates of Validation for three test kits that detect SARS-CoV-2

AOAC INTERNATIONAL announced today that it has issued Certificates of Validation for three proprietary test kits that detect SARS-CoV-2, the causative agent of COVID-19 illness, on environmental surfaces.

18 Dec 2020

Research at Advanced Photon Source laid the groundwork for effective COVID-19 vaccines

There is light at the end of the COVID-19 pandemic tunnel. Several vaccines against the SARS-CoV-2 virus that causes COVID-19 are now in clinical trials, with one -- developed by Pfizer/BioNTech -- already having been approved for emergency use in the United States.

18 Dec 2020

Quantifying SARS-CoV-2 transmission in large urban areas

A team of international researchers used mobility information and socio-demographic data to build a model of SARS-CoV-2 transmission to understand where, when, and how many transmission events occurred in the first wave of the pandemic in the United States.

18 Dec 2020

Novel SARS-CoV-2 neutralizing antibody enters Phase 1/2a clinical study

Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer Ingelheim today announced the initiation of Phase 1/2a clinical investigation of BI 767551, a new SARS-CoV-2 neutralizing antibody.

18 Dec 2020

Higher COVID-19 mortality among certain groups in Colombia linked to structural inequalities

Researchers at the Ministry of Health and Social Protection in Bogotá, Colombia, provided evidence of socioeconomic inequalities in COVID-19 deaths in terms of age, sex, ethnicity, type of health insurance regime, and socioeconomic status.

18 Dec 2020

Very few COVID-19-positive children require hospitalization, finds case study

A team of researchers at the Divisions of Infectious Diseases, UPMC Children’s Hospital of Pittsburgh and the University of Pittsburgh, USA, sought to characterize the clinical presentation of children with COVID-19 in Western Pennsylvania.

18 Dec 2020

Remdesivir inhibits SARS-CoV-2 replication by preventing RdRp-mediated RNA translocation

A new study describes the in vitro mechanism by which remdesivir kinetically inhibits the replication of the virus that causes COVID-19, SARS-CoV-2.

18 Dec 2020

Can online health forums track the effect of COVID-19 on mental health?

A team of researchers at King's College London, UK, and other institutions used publicly accessible sources of real-world data, such as online health forums. They found that authors of COVID-19 related posts most frequently mentioned mental health symptom keywords during the first wave, followed by physical symptoms and intensive care keywords.

18 Dec 2020

Rapid no-frills detection of SARS-CoV-2 in saliva with LAMP-Cas13

A new paper that appeared as a preprint on the medRxiv* server in December 2020 describes a nucleic acid test validated on saliva samples.

18 Dec 2020

Rapid point-of-care lateral flow assay to assess the neutralizing activity of plasma against SARS-CoV-2

A new paper describes the development and validation of a rapid test to measure the neutralizing activity of serum against COVID-19 using a drop of blood.

18 Dec 2020

SARS CoV 2 News and Research

How effective have COVID-19 control measures been in the UK?

COVID-19 spread in cities driven by socioeconomically weaker groups, study finds

SARS-CoV-2 spike protein remains remarkably conserved among 37 variants from Hong Kong

SARS-CoV-2 RNA in serum associated with poor prognosis and high mortality

Cross-reactive coronavirus antibodies shape COVID-19 convalescent plasma functionality

South Korean city shows SARS-CoV-2 clade shift from V to GH over time

Detecting SARS-CoV-2 sequences in blood monocytes

FDA issues first emergency use authorization for second COVID-19 vaccine

Study: COVID-19 pandemic may have contributed to avoidable heart-related deaths in England

Zika infection affects fetal retinal development during pregnancy but not after birth

AOAC INTERNATIONAL issues Certificates of Validation for three test kits that detect SARS-CoV-2

Research at Advanced Photon Source laid the groundwork for effective COVID-19 vaccines

Quantifying SARS-CoV-2 transmission in large urban areas

Novel SARS-CoV-2 neutralizing antibody enters Phase 1/2a clinical study

Higher COVID-19 mortality among certain groups in Colombia linked to structural inequalities

Very few COVID-19-positive children require hospitalization, finds case study

Remdesivir inhibits SARS-CoV-2 replication by preventing RdRp-mediated RNA translocation

Can online health forums track the effect of COVID-19 on mental health?

Rapid no-frills detection of SARS-CoV-2 in saliva with LAMP-Cas13

Rapid point-of-care lateral flow assay to assess the neutralizing activity of plasma against SARS-CoV-2

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News